I expect Alphabet's Cloud investment to expand earnings capacity because coverage reports 82% growth and $24.8 billion in quarterly sales alongside custom TPU spending. I retain, rather than enlarge, the core allocation because revenue growth does not establish cash returns.

What would change the view: I'm wrong if investment persistently consumes its economic gains.

I expect Microsoft's cloud scale to support further profitable reinvestment because coverage reports Azure exceeding $100 billion in annual revenue and development of Maia processors. The 32.72 trailing multiple requires restraint, so I retain the weight.

What would change the view: I'm wrong if infrastructure spending grows without adequate incremental owner earnings.

I expect Amazon's cloud reinvestment to support owner earnings because coverage identifies custom Trainium processors as a route to efficiency. At 21.26 times trailing earnings, I retain measured ownership rather than pay for an assumed outcome.

What would change the view: I'm wrong if chip investment fails to improve economics.

I expect Amphenol to offer satisfactory compounding if its connector earnings remain durable: supplied trailing diluted EPS is $3.92 at 21.91 times earnings. I retain the allocation without treating its recent advance as proof of business quality.

What would change the view: I'm wrong if earnings durability or reinvestment returns deteriorate.

I expect Berkshire's selective capital deployment to benefit continuing owners because coverage describes cash accumulation alongside retained equity ownership and renewed repurchases. I retain its allocation, but a buyback is evidence of management judgment, not proof of cheapness.

What would change the view: I'm wrong if deployment repeatedly destroys per-share value.

I expect JPMorgan to compound through productive capital because coverage reports 20% return on tangible common equity. At 13.84 times trailing earnings, retained profits and distributions offer a sensible ownership case. I maintain the allocation.

What would change the view: I'm wrong if credit losses or funding costs materially erode through-cycle profitability.

I expect Nvidia's existing semiconductor earnings to support continued ownership, with $7.23 trailing diluted EPS at 31.61 times earnings. Current coverage references participation in AI infrastructure, but supplies little new economic detail. I retain the restrained allocation.

What would change the view: I'm wrong if earnings weaken while the valuation still requires growth.

I expect UnitedHealth's improved medical-cost economics to strengthen owner earnings because coverage reports an improved cost ratio and raised guidance. At 19.60 times trailing earnings, I retain a measured healthcare allocation rather than extrapolate the reported rebound.

What would change the view: I'm wrong if medical costs reverse those gains or margins deteriorate.

I expect American Express to compound through retained earnings because coverage reports a 20% payout ratio and raised revenue guidance. Its 18.19 trailing earnings multiple provides a measured starting price. I retain the position rather than chase dividend growth.

What would change the view: I'm wrong if expenses persistently outrun franchise earnings.